A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720)

NCT00617890 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
219
Enrollment
INDUSTRY
Sponsor class

Stopped The study was prematurely terminated for strategic reasons, not for a safety concern.

Conditions

Interventions

Sponsor

Merck Sharp & Dohme LLC